Understanding Biosafety and Containment Levels
Biosafety addresses the safe handling and containment of biohazardous material. It is meant to prevent lab-acquired infections and/or prevent release into agricultural or natural ecosystems.
Containment is achieved through the use of work practices, safety equipment, PPE and facility features.
Containment of biohazardous material is described by 4 biosafety levels: BSL-1, BSL-2, BSL-3, and BSL-4. The higher the number the more dangerous the material. Click below for a more detailed description of these levels.
Standards & Regulations
- Biosafety in Microbiological and Biomedical Laboratories (BMBL)
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
- Bloodborne Pathogens
- Commerce Control List
- EPA (approved disinfectants)
- Select Agents
- Dual Use Research of Concern
- NIH BSL-3 Lab Certification Requirements
2025 Meeting Schedule
Meetings are held on the third Wednesday of each month at 1:30 p.m. at 301 Research Blvd.
When possible and consistent with protection of privacy and proprietary interests, IBC meetings can be made available to the public.
For further information, please contact the IBC Chair, pharr@cvm.msstate.edu, or IBC admin at IBC@research.msstate.edu.
DEADLINE | MEETING DATE |
May 7 | May 21 |
June 4 | June 18 |
July 2 | July 16 |
August 6 | August 20 |
September 3 | September 17 |
October 1 | October 15 |
November 5 | November 19 |
December 3 | December 17 |
For information on how to fill out an IBC application/registration or modification form, or to determine if one should be submitted, please review the FAQ page.
IBC Membership
The IBC is composed of university faculty and staff with expertise in microbiology, molecular biology, animal containment and plant containment. Two community members represent the interest of the surrounding community. Click below to see the current IBC roster.
IBC Standard Operating Procedures (SOPS)
The IBC adheres to SOPs in order to review research in a consistent and fair manner.
MSU Policy on Biosafety
Current IBC SOPs
- IBC Charter
- IBC-PP-004 Annual Executive Review of the IBC
- IBC-PP-005 General Public Comments in IBC Activities
- IBC-PP-006 Use of Consultants in IBC Application Review
- IBC-PP-007 Human Cell Line Policy
- IBC-PP-008 Admin Review of Human/Primate Cell Culture Use
- IBC-PP-009 IBC Application Annual Update/Modification/Termination
- IBC-PP-011 IBC Member/Consultant COI
- IBC-PP-012 IBC Application Submission, Review and Approval
- IBC-PP-014 Confidentiality of IBC Deliberations
- IBC-PP-015 IBC Application Appeals by PI
- IBC-PP-016 Incident Reporting to Federal Agencies
- IBC-PP-017 IBC Member Training
- IBC-PP-018 Annual Report to NIH OBA
- IBC-PP-019 Autoclave Verification
- IBC-PP-024 Public Request and Redaction of IBC Minutes
- IBC-PP-027 IBC Chair Duties
- IBC-PP-028 Suspension/Termination of Previously Approved Research
- IBC-PP-029 IBC Chair Training
- IBC-PP-030 Annual Post Approval Monitoring
- IBC-PP-032 Expiration Dates for IBC Applications
- IBC-PP-033 Edwardsiella ictaluri Biosafety Level Recommendation
- IBC-PP-034 Visitors during IBC Meeting
- IBC-PP-035 Short Term Workers in BSL-2 Labs
- IBC-PP-036 Incidents and Investigations of Incidents
- IBC-SOP-001 NIH Requirements
- IBC-SOP-002 Coordination of Institutional Oversight
- IBC-SOP-003 Animal Associated Risk Notification